Sensorineural Hearing Loss
Pipeline by Development Stage
Competitive Landscape
7 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (15)
Total enrollment: 564 patients across 15 trials
First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant
Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array
Appreciation for Music Processed by Hearing Aids
Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing
Cochlear Implant With Dexamethasone Eluting Electrode Array
Hearing Implant Performance in Adults With Low-Frequency Residual Hearing
Listening Effort in Cochlear Implant Users
Clinical Evaluation of a Cochlear Implant System
Implantation of the Cochlear™ Nucleus® Hybrid S Round Window (S-RW) in Adults
Fundamental Asynchronous Stimulus Timing Sound Coding Study
Esteem New Subject Enrollment Post Approval Study
Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System
Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.